DENNER ALEXANDER J — SEC insider filings
SEC reporting owner CIK 1361754. 46 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 46 filings on record, filed 2020-10-23 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 20 legs across 9 filings — 3,073,000 shares, $32,081,808 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 3 filings — 28,969,044 shares, $98,933,175 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 10,000,000 shares @ $2.59 ($25,900,000) in Iterum Therapeutics plc, filed 2021-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) | 10% owner | 1 | — | 2 legs · 20,619,949 sh · $50,007,284 | 2 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | Director | 33 | 8 legs · 2,350,000 sh · $22,832,210 | 2 legs · 6,730,800 sh · $20,530,448 | 32 |
| Innoviva, Inc. (INVA) | 10% owner | 8 | 12 legs · 723,000 sh · $9,249,598 | 3 legs · 1,618,295 sh · $28,395,442 | — |
| BIOGEN INC. (BIIB) | Director | 2 | — | — | 2 |
| Sarissa Capital Acquisition Corp. (SRSA) | 10% owner | 2 | — | — | 2 |
Insider filings — DENNER ALEXANDER J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 3,694 @ $0 | EDGAR |
| 2026-06-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 4,065 @ $0 · Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-03-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 4,451 @ $0 · Sale (S): 6,725,000 @ $3.05 · Sale (S): 5,800 @ $3.31 | EDGAR |
| 2025-12-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 4,178 @ $0 | EDGAR |
| 2025-09-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 11,718 @ $0 | EDGAR |
| 2025-06-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 24,193 @ $0 | EDGAR |
| 2025-06-12 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-04-04 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 10,416 @ $0 | EDGAR |
| 2025-03-17 | 4/A | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Holdings only — no transactions reported | EDGAR |
| 2025-03-06 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Sale (S): 151,175 @ $17.63 · Sale (S): 270,374 @ $17.63 · Sale (S): 1,196,746 @ $17.52 | EDGAR |
| 2024-12-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 4,249 @ $0 | EDGAR |
| 2024-09-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 3,282 @ $0 | EDGAR |
| 2024-06-21 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 24,311 @ $0 | EDGAR |
| 2024-06-18 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 2,572 @ $0 | EDGAR |
| 2024-03-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,662 @ $0 | EDGAR |
| 2023-12-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,347 @ $0 | EDGAR |
| 2023-09-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,798 @ $0 | EDGAR |
| 2023-06-22 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 22,350 @ $0 | EDGAR |
| 2023-06-20 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 62,000 @ $13.13 | EDGAR |
| 2023-06-20 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,359 @ $0 | EDGAR |
| 2023-06-07 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 7,000 @ $13.04 · Purchase (P): 8,000 @ $13.05 | EDGAR |
| 2023-05-30 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 50,000 @ $13.09 · Purchase (P): 30,000 @ $13.12 · Purchase (P): 120,000 @ $13.01 | EDGAR |
| 2023-05-19 | 4/A | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 50,000 @ $13.07 · Purchase (P): 10,000 @ $13.05 · Purchase (P): 36,000 @ $13.48 | EDGAR |
| 2023-05-19 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 50,000 @ $13.07 · Purchase (P): 10,000 @ $13.05 | EDGAR |
| 2023-05-15 | 4 | Innoviva, Inc. (INVA) jointly with Sarissa Capital Management LP | Purchase (P): 290,000 @ $12.34 | EDGAR |
| 2023-03-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,438 @ $0 | EDGAR |
| 2022-12-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,244 @ $0 | EDGAR |
| 2022-09-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,374 @ $0 | EDGAR |
| 2022-06-17 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,370 @ $0 | EDGAR |
| 2022-06-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,222 @ $0 | EDGAR |
| 2022-06-03 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 21,571 @ $0 | EDGAR |
| 2022-03-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,152 @ $0 | EDGAR |
| 2021-12-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,211 @ $0 | EDGAR |
| 2021-09-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,137 @ $0 | EDGAR |
| 2021-07-02 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 775 @ $0 | EDGAR |
| 2021-06-16 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,229 @ $0 | EDGAR |
| 2021-06-04 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 22,766 @ $0 | EDGAR |
| 2021-03-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Grant/award (A): 1,235 @ $0 | EDGAR |
| 2021-03-10 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Purchase (P): 150,000 @ $10.30 · Purchase (P): 75,000 @ $10.54 | EDGAR |
| 2021-03-05 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) jointly with Sarissa Capital Management LP | Purchase (P): 350,000 @ $10.02 · Purchase (P): 250,000 @ $10 · Purchase (P): 175,000 @ $10.01 | EDGAR |
| 2021-03-02 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Purchase (P): 505,100 @ $9.20 · Purchase (P): 344,900 @ $9.60 · Purchase (P): 500,000 @ $9.56 | EDGAR |
| 2021-02-12 | 4 | Iterum Therapeutics plc (ITRM) jointly with Sarissa Capital Management LP, Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP, Sarissa Capital Master Fund II LP | Conversion (C): 20,619,949 · Sale (S): 10,000,000 @ $2.59 · Sale (S): 10,619,949 @ $2.27 · Conversion (C): 15,000,000 (derivative) | EDGAR |
| 2020-12-17 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 661 @ $0 | EDGAR |
| 2020-11-09 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 12,258 @ $0 · Grant/award (A): 24,925 @ $0 | EDGAR |
| 2020-11-03 | 4 | Sarissa Capital Acquisition Corp. (SRSA) jointly with Sarissa Capital Acquisition Sponsor LLC, Sarissa Capital Management LP, Sarissa Capital Management GP LLC | Other (J): 31,250 (derivative) @ $0 | EDGAR |
| 2020-10-23 | 4 | Sarissa Capital Acquisition Corp. (SRSA) jointly with Sarissa Capital Acquisition Sponsor LLC, Sarissa Capital Management LP, Sarissa Capital Management GP LLC | Purchase (P): 3,333,333 (derivative) @ $1.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-22 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1361754 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs